Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancerReza Ghasemi(Washington University in St. Louis), Stefano IacobelliOncogenesisAugust 18, 201410.1038/oncsis.2014.31Cited by 19SaveCiteExport RISWatch citationsRelated PapersContribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells|Leukemia|2020|30